nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—DRD2—Gilles de la Tourette syndrome	0.468	0.564	CbGaD
Cyproheptadine—HTR2A—Gilles de la Tourette syndrome	0.361	0.436	CbGaD
Cyproheptadine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00685	0.158	CbGeAlD
Cyproheptadine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00412	0.0951	CbGeAlD
Cyproheptadine—HTR6—nervous system—Gilles de la Tourette syndrome	0.0018	0.0415	CbGeAlD
Cyproheptadine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00173	0.0399	CbGeAlD
Cyproheptadine—HTR6—brain—Gilles de la Tourette syndrome	0.00137	0.0317	CbGeAlD
Cyproheptadine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00126	0.0292	CbGeAlD
Cyproheptadine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.00108	0.0249	CbGeAlD
Cyproheptadine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.00106	0.0245	CbGeAlD
Cyproheptadine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00104	0.024	CbGeAlD
Cyproheptadine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00104	0.0239	CbGeAlD
Cyproheptadine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000999	0.0231	CbGeAlD
Cyproheptadine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00098	0.0226	CbGeAlD
Cyproheptadine—Diphenylpyraline—SLC6A3—Gilles de la Tourette syndrome	0.000979	0.137	CrCbGaD
Cyproheptadine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000975	0.0225	CbGeAlD
Cyproheptadine—DRD2—midbrain—Gilles de la Tourette syndrome	0.00096	0.0222	CbGeAlD
Cyproheptadine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000944	0.0218	CbGeAlD
Cyproheptadine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000939	0.0217	CbGeAlD
Cyproheptadine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000877	0.0203	CbGeAlD
Cyproheptadine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000874	0.0202	CbGeAlD
Cyproheptadine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.000866	0.02	CbGeAlD
Cyproheptadine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000844	0.0195	CbGeAlD
Cyproheptadine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000841	0.0194	CbGeAlD
Cyproheptadine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000834	0.0193	CbGeAlD
Cyproheptadine—CHRM2—brain—Gilles de la Tourette syndrome	0.000823	0.019	CbGeAlD
Cyproheptadine—HTR2C—brain—Gilles de la Tourette syndrome	0.000793	0.0183	CbGeAlD
Cyproheptadine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000789	0.0182	CbGeAlD
Cyproheptadine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.00076	0.0176	CbGeAlD
Cyproheptadine—CHRM1—brain—Gilles de la Tourette syndrome	0.000749	0.0173	CbGeAlD
Cyproheptadine—HTR2B—brain—Gilles de la Tourette syndrome	0.000745	0.0172	CbGeAlD
Cyproheptadine—CHRM3—brain—Gilles de la Tourette syndrome	0.00067	0.0155	CbGeAlD
Cyproheptadine—HTR1A—brain—Gilles de la Tourette syndrome	0.000668	0.0154	CbGeAlD
Cyproheptadine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000662	0.0153	CbGeAlD
Cyproheptadine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000633	0.0146	CbGeAlD
Cyproheptadine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000623	0.0144	CbGeAlD
Cyproheptadine—DRD2—brain—Gilles de la Tourette syndrome	0.000603	0.0139	CbGeAlD
Cyproheptadine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.0006	0.0139	CbGeAlD
Cyproheptadine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000521	0.012	CbGeAlD
Cyproheptadine—Mianserin—DRD3—Gilles de la Tourette syndrome	0.000502	0.0704	CrCbGaD
Cyproheptadine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000501	0.0116	CbGeAlD
Cyproheptadine—HRH1—brain—Gilles de la Tourette syndrome	0.000476	0.011	CbGeAlD
Cyproheptadine—Cyclobenzaprine—HTR2A—Gilles de la Tourette syndrome	0.000467	0.0656	CrCbGaD
Cyproheptadine—Mianserin—SLC6A3—Gilles de la Tourette syndrome	0.000467	0.0655	CrCbGaD
Cyproheptadine—Loxapine—DRD4—Gilles de la Tourette syndrome	0.000463	0.0649	CrCbGaD
Cyproheptadine—Loxapine—DRD3—Gilles de la Tourette syndrome	0.000399	0.0559	CrCbGaD
Cyproheptadine—HTR2A—brain—Gilles de la Tourette syndrome	0.000398	0.00919	CbGeAlD
Cyproheptadine—Clozapine—DRD4—Gilles de la Tourette syndrome	0.000388	0.0545	CrCbGaD
Cyproheptadine—Loxapine—SLC6A3—Gilles de la Tourette syndrome	0.000371	0.052	CrCbGaD
Cyproheptadine—Mianserin—DRD2—Gilles de la Tourette syndrome	0.000347	0.0487	CrCbGaD
Cyproheptadine—Clozapine—DRD3—Gilles de la Tourette syndrome	0.000335	0.047	CrCbGaD
Cyproheptadine—Amitriptyline—DRD3—Gilles de la Tourette syndrome	0.000311	0.0437	CrCbGaD
Cyproheptadine—Nortriptyline—DRD2—Gilles de la Tourette syndrome	0.000311	0.0435	CrCbGaD
Cyproheptadine—Loxapine—DRD2—Gilles de la Tourette syndrome	0.000276	0.0387	CrCbGaD
Cyproheptadine—Mianserin—HTR2A—Gilles de la Tourette syndrome	0.000268	0.0376	CrCbGaD
Cyproheptadine—Nortriptyline—HTR2A—Gilles de la Tourette syndrome	0.00024	0.0337	CrCbGaD
Cyproheptadine—Clozapine—DRD2—Gilles de la Tourette syndrome	0.000232	0.0325	CrCbGaD
Cyproheptadine—Amitriptyline—DRD2—Gilles de la Tourette syndrome	0.000215	0.0302	CrCbGaD
Cyproheptadine—Loxapine—HTR2A—Gilles de la Tourette syndrome	0.000213	0.0299	CrCbGaD
Cyproheptadine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000207	0.00172	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000205	0.0017	CbGpPWpGaD
Cyproheptadine—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000198	0.00165	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—HDC—Gilles de la Tourette syndrome	0.000197	0.00164	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000197	0.00164	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000194	0.00161	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000193	0.0016	CbGpPWpGaD
Cyproheptadine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000192	0.0016	CbGpPWpGaD
Cyproheptadine—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000192	0.0016	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000191	0.00159	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000189	0.00157	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000187	0.00156	CbGpPWpGaD
Cyproheptadine—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000186	0.00154	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000184	0.00153	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000183	0.00152	CbGpPWpGaD
Cyproheptadine—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000179	0.00149	CbGpPWpGaD
Cyproheptadine—Clozapine—HTR2A—Gilles de la Tourette syndrome	0.000179	0.0251	CrCbGaD
Cyproheptadine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000178	0.00148	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000178	0.00147	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000176	0.00146	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000174	0.00145	CbGpPWpGaD
Cyproheptadine—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000174	0.00145	CbGpPWpGaD
Cyproheptadine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000174	0.00144	CbGpPWpGaD
Cyproheptadine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000169	0.0014	CbGpPWpGaD
Cyproheptadine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000168	0.0014	CbGpPWpGaD
Cyproheptadine—Amitriptyline—HTR2A—Gilles de la Tourette syndrome	0.000167	0.0234	CrCbGaD
Cyproheptadine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000166	0.00138	CbGpPWpGaD
Cyproheptadine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000166	0.00138	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000165	0.00137	CbGpPWpGaD
Cyproheptadine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000163	0.00135	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000162	0.00135	CbGpPWpGaD
Cyproheptadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000161	0.00134	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000159	0.00132	CbGpPWpGaD
Cyproheptadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000158	0.00132	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000158	0.00131	CbGpPWpGaD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000157	0.00131	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000157	0.00131	CbGpPWpGaD
Cyproheptadine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000157	0.00131	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000157	0.00131	CbGpPWpGaD
Cyproheptadine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000157	0.0013	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000157	0.0013	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000156	0.00129	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000154	0.00128	CbGpPWpGaD
Cyproheptadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000154	0.00128	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000153	0.00127	CbGpPWpGaD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000153	0.00127	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000153	0.00127	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000152	0.00126	CbGpPWpGaD
Cyproheptadine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000152	0.00126	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000151	0.00126	CbGpPWpGaD
Cyproheptadine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00015	0.00124	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000148	0.00123	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000148	0.00123	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000147	0.00122	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000144	0.00119	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000144	0.00119	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000144	0.00119	CbGpPWpGaD
Cyproheptadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000143	0.00119	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000143	0.00119	CbGpPWpGaD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000142	0.00118	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000142	0.00118	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000142	0.00118	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000141	0.00117	CbGpPWpGaD
Cyproheptadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000138	0.00115	CbGpPWpGaD
Cyproheptadine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000136	0.00113	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000136	0.00113	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000135	0.00112	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000135	0.00112	CbGpPWpGaD
Cyproheptadine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000135	0.00112	CbGpPWpGaD
Cyproheptadine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000134	0.00111	CbGpPWpGaD
Cyproheptadine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000134	0.00111	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000134	0.00111	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000134	0.00111	CbGpPWpGaD
Cyproheptadine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000132	0.0011	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000132	0.00109	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000131	0.00109	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000131	0.00109	CbGpPWpGaD
Cyproheptadine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00013	0.00108	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00013	0.00108	CbGpPWpGaD
Cyproheptadine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000129	0.00107	CbGpPWpGaD
Cyproheptadine—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000129	0.00107	CbGpPWpGaD
Cyproheptadine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000123	0.00102	CbGpPWpGaD
Cyproheptadine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000123	0.00102	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000123	0.00102	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000122	0.00102	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000122	0.00101	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000121	0.001	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00012	0.000996	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000119	0.000991	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000116	0.000967	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000116	0.000967	CbGpPWpGaD
Cyproheptadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000116	0.000964	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000116	0.000962	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000116	0.000962	CbGpPWpGaD
Cyproheptadine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000116	0.000961	CbGpPWpGaD
Cyproheptadine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000115	0.000958	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000108	0.000901	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000108	0.000896	CbGpPWpGaD
Cyproheptadine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000105	0.000876	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000105	0.000875	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000104	0.00086	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000103	0.000859	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000103	0.000856	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000103	0.000853	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000103	0.000852	CbGpPWpGaD
Cyproheptadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000102	0.000849	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000102	0.000849	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000102	0.000845	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000101	0.000835	CbGpPWpGaD
Cyproheptadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0001	0.000834	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0001	0.000834	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0001	0.000831	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0001	0.000831	CbGpPWpGaD
Cyproheptadine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.97e-05	0.000828	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.97e-05	0.000828	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.97e-05	0.000828	CbGpPWpGaD
Cyproheptadine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.92e-05	0.000824	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.88e-05	0.00082	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.88e-05	0.00082	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	9.85e-05	0.000818	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.37e-05	0.000778	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.37e-05	0.000778	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.35e-05	0.000777	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.32e-05	0.000774	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.29e-05	0.000772	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.2e-05	0.000764	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.16e-05	0.00076	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.89e-05	0.000738	CbGpPWpGaD
Cyproheptadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.76e-05	0.000727	CbGpPWpGaD
Cyproheptadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.6e-05	0.000714	CbGpPWpGaD
Cyproheptadine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.57e-05	0.000712	CbGpPWpGaD
Cyproheptadine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.54e-05	0.00071	CbGpPWpGaD
Cyproheptadine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.46e-05	0.000703	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.36e-05	0.000694	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.31e-05	0.000691	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.28e-05	0.000688	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.11e-05	0.000674	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.07e-05	0.00067	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.6e-05	0.000631	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.59e-05	0.00063	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.56e-05	0.000628	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.56e-05	0.000628	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.52e-05	0.000624	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.37e-05	0.000612	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.86e-05	0.00057	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.78e-05	0.000563	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.74e-05	0.00056	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.67e-05	0.000554	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.58e-05	0.000546	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.55e-05	0.000544	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.55e-05	0.000544	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.53e-05	0.000542	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.51e-05	0.00054	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.44e-05	0.000535	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.15e-05	0.000511	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.13e-05	0.000509	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.12e-05	0.000509	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.1e-05	0.000506	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.97e-05	0.000496	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.95e-05	0.000494	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.94e-05	0.000494	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.85e-05	0.000486	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.84e-05	0.000485	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.82e-05	0.000484	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.8e-05	0.000482	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.8e-05	0.000482	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.78e-05	0.00048	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.75e-05	0.000477	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.68e-05	0.000472	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.67e-05	0.000471	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.65e-05	0.00047	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.64e-05	0.000468	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.58e-05	0.000464	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.57e-05	0.000462	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.54e-05	0.00046	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.4e-05	0.000449	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.32e-05	0.000442	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.31e-05	0.000441	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.29e-05	0.00044	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.29e-05	0.00044	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.29e-05	0.000439	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.28e-05	0.000439	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.27e-05	0.000438	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.27e-05	0.000437	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.27e-05	0.000437	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.25e-05	0.000436	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.25e-05	0.000436	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.22e-05	0.000434	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.2e-05	0.000432	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.16e-05	0.000429	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.15e-05	0.000428	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.13e-05	0.000426	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.12e-05	0.000425	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.07e-05	0.000421	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.91e-05	0.000408	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.81e-05	0.000399	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.81e-05	0.000399	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.8e-05	0.000398	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.78e-05	0.000397	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.77e-05	0.000396	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.77e-05	0.000396	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.72e-05	0.000392	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.48e-05	0.000372	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.44e-05	0.000369	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.35e-05	0.000361	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.29e-05	0.000357	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.27e-05	0.000355	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.05e-05	0.000337	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.9e-05	0.000324	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.88e-05	0.000322	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.77e-05	0.000313	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.7e-05	0.000307	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.69e-05	0.000306	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.68e-05	0.000305	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.64e-05	0.000302	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.64e-05	0.000302	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.62e-05	0.0003	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.53e-05	0.000293	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.51e-05	0.000292	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.42e-05	0.000284	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.36e-05	0.000279	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.35e-05	0.000278	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.34e-05	0.000277	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.31e-05	0.000275	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.29e-05	0.000273	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.27e-05	0.000272	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.19e-05	0.000265	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.14e-05	0.000261	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.13e-05	0.00026	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.12e-05	0.000259	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.11e-05	0.000259	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.11e-05	0.000258	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.1e-05	0.000257	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.08e-05	0.000256	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.05e-05	0.000253	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.04e-05	0.000253	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.03e-05	0.000252	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.02e-05	0.000251	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.99e-05	0.000249	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.84e-05	0.000236	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.84e-05	0.000236	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.83e-05	0.000235	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.83e-05	0.000235	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.82e-05	0.000234	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.79e-05	0.000232	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.3e-05	0.000191	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.00019	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.000168	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.99e-05	0.000165	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.98e-05	0.000164	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000164	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.95e-05	0.000162	CbGpPWpGaD
